Tyrosine Kinase


Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
A1389 WZ4002Summary: Mutant-selective EGFR inhibitor(L858R,T790M), irreversible and potent -
A5096 PF-04217903Target: c-METSummary: C-Met inhibitor,selective and ATP-competitive -
A1196 SGX-5231 CitationTarget: METSummary: MET inibitor, highly selective, ATP-competitive -
A2949 Linifanib (ABT-869)Target: VEGFR|PDGFRSummary: VEGFR/PDGFR inhibitor -
A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: IGF-1R/InsR inhibitor,potent and selective -
A1805 Imatinib Mesylate (STI571)2 CitationTarget: PDGFR|c-Kit|Bcr-AblSummary: Abl/c-kit/PDGFR inhibitor -
A2168 Dovitinib (TKI-258, CHIR-258)2 CitationTarget: FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: Multitargeted RTK inhibitor -
A1882 Cediranib (AZD217)Target: VEGFRSummary: VEGFR inhibitor receptor,highly potent -
A2977 Cabozantinib (XL184, BMS-907351)3 CitationSummary: VEGFR2/Met/Ret/Kit/FLT//AXL inhibitor -
A5092 JNJ-38877605Summary: C-Met inhibitor,ATP-competitive

